These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19200051)

  • 1. The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate's activity in cancer cells.
    Konkimalla VB; McCubrey JA; Efferth T
    Curr Cancer Drug Targets; 2009 Feb; 9(1):72-80. PubMed ID: 19200051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting EGFR-mediated autophagy as a potential strategy for cancer therapy.
    Sooro MA; Zhang N; Zhang P
    Int J Cancer; 2018 Nov; 143(9):2116-2125. PubMed ID: 29574749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells.
    Youns M; Efferth T; Reichling J; Fellenberg K; Bauer A; Hoheisel JD
    Biochem Pharmacol; 2009 Aug; 78(3):273-83. PubMed ID: 19393226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
    Efferth T
    Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells.
    Konkimalla VB; Blunder M; Korn B; Soomro SA; Jansen H; Chang W; Posner GH; Bauer R; Efferth T
    Nitric Oxide; 2008 Sep; 19(2):184-91. PubMed ID: 18472018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.
    Lee S; Heinrich EL; Lu J; Lee W; Choi AH; Luu C; Chung V; Fakih M; Kim J
    Pancreas; 2016 Feb; 45(2):286-92. PubMed ID: 26262587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship of epidermal growth factor receptor in lung development].
    Li HJ; Liu Y; Hao HS; DU WH; Zhao XM; Wang D; Qin T; Ma YJ; Zhu HB
    Yi Chuan; 2012 Jan; 34(1):27-32. PubMed ID: 22306870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins.
    Shi H; Zhang T; Yi Y; Ma Y
    Oncol Rep; 2016 Jun; 35(6):3593-9. PubMed ID: 27004682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
    Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
    Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
    Uribe P; Gonzalez S
    Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib.
    Servidei T; Riccardi A; Mozzetti S; Ferlini C; Riccardi R
    Int J Cancer; 2008 Dec; 123(12):2939-49. PubMed ID: 18803287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.
    Efferth T; Ramirez T; Gebhart E; Halatsch ME
    Biochem Pharmacol; 2004 May; 67(9):1689-700. PubMed ID: 15081868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
    Jiang W; Li B; Zheng X; Liu X; Cen Y; Li J; Pan X; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2011 Aug; 11(8):1065-73. PubMed ID: 21396483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
    Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
    J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.
    Monroe JD; Basheer F; Gibert Y
    Cells; 2021 May; 10(5):. PubMed ID: 34067095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
    Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer.
    Ray K; Ujvari B; Ramana V; Donald J
    Cytokine Growth Factor Rev; 2018 Jun; 41():18-27. PubMed ID: 29680500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.